SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : China Warehouse- More Than Crockery
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RealMuLan who wrote (4044)1/3/2005 2:04:26 PM
From: RealMuLan  Read Replies (1) of 6370
 
Some details about India issues decree on patent law --

"The government issued a presidential decree on Sunday to bring its patent laws into compliance with commitments under the World Trade Organisation (WTO) agreement, Commerce Minister Kamal Nath told Reuters. Although details of the decree were not available, it signals a breakthrough in patent reform, which had been stalled by political concerns that reforms would result in higher drug prices. The ruling Congress-led coalition has been under pressure from its powerful communist allies, who want adequate safeguards in the amended patent laws to ensure that prices of medicines would remain stable. India's communist parties and other political parties fear that firms holding product patents for life-saving drugs will increase prices once the new laws come into force. The government had been scheduled to introduce legislation on changing patent laws in the just-concluded winter session of parliament but could not do so due to differences with its communist allies. Commerce and Industry Minister Nath, a businessman turned politician, did not elaborate but told Reuters that he would hold a news conference on Monday to announce the details. India currently has patents for processes but not for products. It must implement them by Jan. 1, 2005, under WTO commitments. The change in India's patent laws is aimed at spurring innovative drug companies to switch away from making copycat generic drugs. New options include making generic drugs for booming export markets, contract research and manufacturing, and new drug research. "

indiadaily.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News